TNF and Alzheimer disease: Recently, a novel strategy of targeting the TNF pathway that selectively inhibits proinflammatory and neurotoxic pathways mediated by TNFR1 while preserving the neuroprotective pathway mediated by TNFR2 to counteract Aβ pathology has been proposed,225 which may advance immunotherapy for AD.